SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > SQI can help, but must first speak up. COMPASSION please

<< Previous

Bullboard Posts

Next >>

Comment by 25Stone7859on Dec 30, 2022 5:27pm

156 Views

Post# 35197841

RE:RE:SQI can help, but must first speak up. COMPASSION please

China, if at all, is light years away. They have 65,000 hospitals.... not a chance. Meanwhile there is no FDA or EU approval so it's Canada which gave approval two months ago but have any provinces or hospitals bought in ? If each test costs $400, which I think is really high, imagine what the RALI dx unit itself costs...
Empathy and compassion are truly altruistic and noble but we need to see sales figures and realistic estimates not musings from the top to get the ball rolling.
Maybe the upcoming MD&A will tell us something.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”